Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

2019 Annual Report

From Start – to Cancer is Finished.

Sean Parker’s vision for the Parker Institute for Cancer Immunotherapy (PICI) has been clear from the beginning: bring the top researchers together, give them everything they need to pursue and push their best ideas forward and eliminate the barriers in their way.

In just over three years, we’ve been hard at work, putting that vision into action. We work hand-in-hand with our network and experts across the field to supercharge scientific discoveries that answer the fundamental questions in cancer immunotherapy. We launch and manage novel clinical trials with the goal of getting the best treatments to patients. We build systems that aggregate and process data – making every initiative more informed than the last and providing direction for where to go next. And we invest in emerging companies with bold ideas and work with industry partners to help us propel our research.

In short, we’re transforming the way cancer research is done to save lives. Faster.

Our progress speaks for itself. Take a look at our report to see what we’ve achieved over the past year.